Zepp Health (NYSE:ZEPP) Given a $64.37 Price Target at Fundamental Research

Zepp Health (NYSE:ZEPP) has been assigned a $64.37 price target by Fundamental Research in a research note issued on Tuesday,BayStreet.CA reports. The firm presently has a “buy” rating on the stock. Fundamental Research’s price objective indicates a potential upside of 147.51% from the stock’s previous close.

ZEPP has been the subject of several other research reports. Weiss Ratings restated a “sell (d-)” rating on shares of Zepp Health in a research report on Wednesday, October 8th. Wall Street Zen upgraded shares of Zepp Health to a “hold” rating in a research note on Saturday, August 16th. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Zepp Health currently has a consensus rating of “Hold” and an average price target of $64.37.

Zepp Health Price Performance

Shares of NYSE:ZEPP traded up $3.61 during midday trading on Tuesday, reaching $26.01. 306,087 shares of the company’s stock were exchanged, compared to its average volume of 295,090. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.78 and a current ratio of 1.09. The company’s 50 day simple moving average is $46.80 and its two-hundred day simple moving average is $24.06. Zepp Health has a 12 month low of $2.13 and a 12 month high of $61.85. The firm has a market capitalization of $377.10 million, a PE ratio of -6.28 and a beta of 1.27.

Institutional Trading of Zepp Health

A hedge fund recently bought a new stake in Zepp Health stock. Trivest Advisors Ltd bought a new position in shares of Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 294,947 shares of the company’s stock, valued at approximately $13,503,000. Zepp Health makes up about 0.4% of Trivest Advisors Ltd’s holdings, making the stock its 23rd biggest holding. Trivest Advisors Ltd owned 2.03% of Zepp Health as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 52.61% of the company’s stock.

Zepp Health Company Profile

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.